Congresso Sir, tra prevenzione e cura
(Adnkronos) - Vaccini, tutela dei pazienti fragili e nuove frontiere per la cura di malattie rare
Category
🗞
NewsTranscript
00:00 Vaccines, prevention, care for fragile patients, new frontiers for the cure of rare diseases.
00:11 The National Congress of the Italian Society of Rehomatology in Rimini has addressed with 60 sessions
00:17 the main rheumatological diseases, not only, on the prevention and large space for vaccines,
00:22 especially for fragile subjects.
00:24 The emergence of zoster herpes, for example, for patients affected by rheumatic diseases in immunomodulating or immunosuppressive therapy, the risks are greater.
00:34 It is more frequent in our patients to develop atypical manifestations, such as the ophthalmic herpes,
00:42 or the disseminated form of zoster, or an intracranial vasculitis.
00:48 This vasculitis of the central nervous system increases the risk of ictus, and therefore of death.
00:54 The vaccine approach to fragile patients has been revolutionized since the arrival in our country of the adjuvated recombinant vaccine.
01:02 A vaccine with a very high profile of effectiveness and which can also be used in the immunocompromised patient in safety.
01:12 Moreover, it is a vaccine that has proven to be effective not only in the prevention of zoster herpes,
01:18 but also in the comparison of post-herpetic neuralgia, which is one of the most feared complications.
01:23 The SIR has been in the forefront for years to recommend vaccination as prevention.
01:28 Society is still very active today, using the SIR Web TV channel for the association of patients,
01:40 with webinars dedicated to colleagues, specialists, rheumatologists, but also doctors in general,
01:46 with mini-pills, and finally there will also be recommendations that will be given in 2024
01:54 about vaccinations of patients with rheumatological diseases.
01:58 In the symposium on the new treatment horizons, the GPs were treated the results of the drug Polizumab,
02:04 both for the remission of disease and for the reduction of corticosteroids.
02:08 The use of this drug has significantly reduced the number of patients with disease,
02:12 and perhaps even more important from a clinical point of view for these patients,
02:16 which helps us significantly reduce the use of corticosteroids.
02:21 It is something that is fundamental in the management of patients with GPs,
02:27 because until a few years ago it was quite unthinkable to be able to remove corticosteroids therapy in these patients.
02:35 Today, however, it is absolutely possible thanks to the use of Polizumab.
02:39 much.
02:39 [BLANK_AUDIO]